Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Richette

Showing results (251-260 of 307) with videos related to

Pageof 31
Sort By:
Drugs & Aging|February 22, 2015
Can we identify patients with high risk of osteoarthritis progression who will respond to treatment? A focus on epidemiology and phenotype of osteoarthritisOlivier Bruyère, Cyrus Cooper, Nigel Arden, et al.
Arthritis Care & Research|November 14, 2025
Response to allopurinol and febuxostat according to the fractional excretion of urate in men with goutPascal Richette, Anouk Walter-Petrich, Quang Dinh Nguyen, et al.
Drugs & Aging|March 29, 2017
Erratum to: Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Epidemiology and Phenotype of OsteoarthritisOlivier Bruyère, Cyrus Cooper, Nigel Arden, et al.
Rheumatology (Oxford, England)|May 22, 2023
Retention, safety and efficacy of off-label conventional treatments and biologics for chronic calcium pyrophosphate crystal inflammatory arthritisJulien Damart, Georgios Filippou, Mariano Andrès, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|August 23, 2020
Incidence Rates of Interstitial Lung Disease Events in Tofacitinib-Treated Rheumatoid Arthritis Patients: Post Hoc Analysis From 21 Clinical TrialsGustavo Citera, Eduardo Mysler, Hugo Madariaga, et al.
Annals of the Rheumatic Diseases|January 16, 2015
Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxibMarc C Hochberg, Johanne Martel-Pelletier, Jordi Monfort, et al.
Rheumatology (Oxford, England)|January 6, 2017
Safety of surgery in patients with rheumatoid arthritis treated by abatacept: data from the French Orencia in Rheumatoid Arthritis RegistryAugustin Latourte, Jacques-Eric Gottenberg, Cécile Luxembourger, et al.
Joint Bone Spine|August 10, 2013
The learning curve of nurses for the assessment of swollen and tender joints in rheumatoid arthritisPeter P Cheung, Maxime Dougados, Vincent Andre, et al.
Joint Bone Spine|March 10, 2021
The DIGICOD cohort: A hospital-based observational prospective cohort of patients with hand osteoarthritis - methodology and baseline characteristics of the populationJérémie Sellam, Emmanuel Maheu, Michel D Crema, et al.
Joint Bone Spine|September 25, 2012
Improving agreement in assessment of synovitis in rheumatoid arthritisPeter P Cheung, Maxime Dougados, Vincent Andre, et al.
Pageof 31

Showing results (251-260 of 307) with videos related to

Sort By:
Pageof 31
Drugs & Aging|February 22, 2015
Can we identify patients with high risk of osteoarthritis progression who will respond to treatment? A focus on epidemiology and phenotype of osteoarthritisOlivier Bruyère, Cyrus Cooper, Nigel Arden, et al.
Arthritis Care & Research|November 14, 2025
Response to allopurinol and febuxostat according to the fractional excretion of urate in men with goutPascal Richette, Anouk Walter-Petrich, Quang Dinh Nguyen, et al.
Drugs & Aging|March 29, 2017
Erratum to: Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Epidemiology and Phenotype of OsteoarthritisOlivier Bruyère, Cyrus Cooper, Nigel Arden, et al.
Rheumatology (Oxford, England)|May 22, 2023
Retention, safety and efficacy of off-label conventional treatments and biologics for chronic calcium pyrophosphate crystal inflammatory arthritisJulien Damart, Georgios Filippou, Mariano Andrès, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|August 23, 2020
Incidence Rates of Interstitial Lung Disease Events in Tofacitinib-Treated Rheumatoid Arthritis Patients: Post Hoc Analysis From 21 Clinical TrialsGustavo Citera, Eduardo Mysler, Hugo Madariaga, et al.
Annals of the Rheumatic Diseases|January 16, 2015
Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxibMarc C Hochberg, Johanne Martel-Pelletier, Jordi Monfort, et al.
Rheumatology (Oxford, England)|January 6, 2017
Safety of surgery in patients with rheumatoid arthritis treated by abatacept: data from the French Orencia in Rheumatoid Arthritis RegistryAugustin Latourte, Jacques-Eric Gottenberg, Cécile Luxembourger, et al.
Joint Bone Spine|August 10, 2013
The learning curve of nurses for the assessment of swollen and tender joints in rheumatoid arthritisPeter P Cheung, Maxime Dougados, Vincent Andre, et al.
Joint Bone Spine|March 10, 2021
The DIGICOD cohort: A hospital-based observational prospective cohort of patients with hand osteoarthritis - methodology and baseline characteristics of the populationJérémie Sellam, Emmanuel Maheu, Michel D Crema, et al.
Joint Bone Spine|September 25, 2012
Improving agreement in assessment of synovitis in rheumatoid arthritisPeter P Cheung, Maxime Dougados, Vincent Andre, et al.
Pageof 31